Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Trends Cardiovasc Med ; 31(6): 333-338, 2021 08.
Article in English | MEDLINE | ID: mdl-32592746

ABSTRACT

Here we describe various techniques for visualization of the lymphatic vasculature, particularly in the heart. Addressing macro-, microscopic, and molecular levels of lymphatic organization, we give examples of how to explore the roles of specific antigens/markers expressed in lymphatic vessels and their extracellular matrix as structural and functional elements involved in various biological functions of lymphatics. Some obstacles and technical challenges related to lymphatic visualization are also discussed.


Subject(s)
Cardiac Imaging Techniques , Heart Diseases/diagnostic imaging , Heart/diagnostic imaging , Lymphatic Diseases/diagnostic imaging , Lymphatic System/diagnostic imaging , Lymphography , Microscopy , Biomarkers/metabolism , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Glycocalyx/metabolism , Glycocalyx/pathology , Heart/physiopathology , Heart Diseases/metabolism , Heart Diseases/pathology , Heart Diseases/physiopathology , Humans , Lymphatic Diseases/metabolism , Lymphatic Diseases/pathology , Lymphatic Diseases/physiopathology , Lymphatic System/metabolism , Lymphatic System/pathology , Lymphatic System/physiopathology , Myocardium/metabolism , Myocardium/pathology , Predictive Value of Tests , Prognosis
2.
Regul Toxicol Pharmacol ; 108: 104478, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31539568

ABSTRACT

Worldwide, drug-induced liver injury (DILI) is a major cause of hepatic failure. It is also the leading cause of withdrawal, cautionary labeling, and restricted usage of licensed drugs; therefore, European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) warn that the existing methods of assessing DILI are insufficient and that some of the translational biomarkers of hepatotoxicity must be relooked. Magnetic resonance imaging (MRI) seems to be a proper tool in elucidating the effects of DILI in both preclinical and clinical studies, providing excellent visualization of the morphology of the liver parenchyma. Therefore, herein, we propose preclinical MRI assessment of liver injury in experimental paracetamol-treated rats. Quantitative MRI clearly provides evidence of adverse effects in the liver tissue caused by a single overdose of paracetamol (1 g kg-1 and 1.5 g kg-1 b.w.). The results of the MRI were confirmed by the histopathological examination (H&E) of the rat liver specimen, however the adverse effects were not disclosed due to standard aminotransferase assays (ALT/AST) in rat blood serum. The results of our analysis demonstrate the successful application of MRI in the examination of paracetamol-induced hepatotoxicity in rats; it has a potential to serve as the early diagnostic tool for the prediction of DILI in preclinical evaluation.


Subject(s)
Acetaminophen/adverse effects , Analgesics/adverse effects , Chemical and Drug Induced Liver Injury/diagnostic imaging , Magnetic Resonance Imaging , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Chemical and Drug Induced Liver Injury/blood , Chemical and Drug Induced Liver Injury/pathology , Drug Evaluation, Preclinical , Female , Liver/diagnostic imaging , Liver/drug effects , Liver/pathology , Rats, Wistar
3.
J Vet Res ; 63(2): 243-249, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31276064

ABSTRACT

INTRODUCTION: The clinical symptoms of portosystemic shunts (PSSs) and hepatic microvascular dysplasia (HMD) - portal vein hypoplasia (PVH) in dogs are similar. PSSs are abnormal vascular connections between the portal vein system and systemic veins. HMD is a very rare developmental vascular anomaly, recognisable during histopathological examination. The study aim was to assess the prevalence of HMD-PVH and hepatocellular and vascular pathologies in the liver. MATERIAL AND METHODS: Liver biopsies from 140 dogs (of different breeds and both sexes) arousing clinical suspicion of PSS were examined histopathologically. RESULTS: An initial PSS diagnosis was confirmed in 125 dogs (89.29%). HMD-PVH was found in 12.32% of dogs, as an isolated disease in 9.29%, especially in Yorkshire terriers, and with extrahepatic PSS in 6.67%. Histopathological analysis of muscles around sublobular veins showed that HMD cases presented hypertrophy or hypertrophy with fibrosis. In 2.17% of all dogs with liver vascular developmental disorders calcification was visible around vessels (without correlation by degenerative changes in those vessels), suggesting prior onset of deep metabolic disorders. Clinical suspicion of PSS was also formed upon quite different pathological processes in young dogs. CONCLUSION: Histopathological findings diagnosed the type of vascular anomalies (PSS or HMD-PVH) or other pathological changes conclusively, therefore detailed hepatic histopathology is an indispensable component of the clinical diagnostic process.

SELECTION OF CITATIONS
SEARCH DETAIL
...